Identification of large-scale molecular changes 1 of Autotaxin(ENPP2) knock-down by small interfering RNA in breast cancer cells

Molecular and Cellular Biochemistry

Volumn 288, Issue 1-2, 2006, Pages 91-106

  Noh, Ji Heon ^a   Ryu, So Yeon ^a   Eun, Jung Woo ^a   Song, Jaehwi ^a   Ahn, Young Min ^c   Kim, Su Young ^a   Lee, Sug Hyung ^a   Park, Won Sang ^a   Yoo, Nam Jin ^a   Lee, Jung Young ^a   Lee, Shi Nae ^b   Nam, Suk Woo ^a  

^a The Catholic University of Korea   (South Korea)

^b Ewha Womans University School of Medicine   (South Korea)

^c Kyung Hee University   (South Korea)

Author keywords

Autotaxin; DNA microarray; ENPP2; lysoPLD; RNA interference

Indexed keywords

AUTOTAXIN; BIOLOGICAL MARKER; GLYCOPROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; BIOGENESIS; BREAST CANCER; CANCER CELL; CELL METABOLISM; CONTROLLED STUDY; CYTOSKELETON; DNA MICROARRAY; DRUG TARGETING; GENE FUNCTION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN TARGETING; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; TRANSCRIPTION REGULATION; UNINDEXED SEQUENCE; UPREGULATION;

BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; HUMANS; MULTIENZYME COMPLEXES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHODIESTERASE I; PYROPHOSPHATASES; RNA INTERFERENCE; RNA, SMALL INTERFERING; TIME FACTORS; TRANSFECTION;

EID: 33748204162     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-006-9124-8     Document Type: Article

References (22)

1. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 100: 57-70, 2000
2. Liotta LA, Mandler R, Murano G, Katz DA, Gordon RK, Chiang PK, Schiffmann E: Tumor cell autocrine motility factor. Proc Natl Acad Sci USA 83: 3302-3306, 1996
3. Stracke ML, Krutzsch HC, Unsworth EJ, Arestad A, Cioce V, Schiffmann E, Liotta LA: Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. J Biol Chem 267: 2524-2529, 1992
4. Clair T, Lee HY, Liotta LA, Stracke ML: Autotaxin is an exoenzyme possessing 5′-nucleotide phosphodiesterase/ATP pyrophosphatase and ATPase activities. J Biol Chem 272: 996-1001, 1997
5. Lee HY, Clair T, Mulvaney PT, Woodhouse EC, Aznavoorian S, Liotta LA, Stracke ML: Stimulation of tumor cell motility linked to phosphodiesterase catalytic site of autotaxin. J Biol Chem 271: 24408-24412, 1996
6. Nam SW, Clair T, Campo CK, Lee HY, Liotta LA, Stracke ML: Autotaxin (ATX), a potent tumor motogen, augments invasive and metastatic potential of ras-transformed cells. Oncogene 19: 241-247, 2000
7. Nam SW, Clair T, Kim YS, McMarlin A, Schiffmann E, Liotta LA, Stracke ML: Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor. Cancer Res 61: 6938-6944, 2001
8. Clair T, Krutzsch HC, Liotta LA, Stracke ML: Nucleotide binding to autotaxin: Crosslinking of bound substrate followed by lysC digestion identifies two labeled peptides. Biochem Biophys Res Commun 236: 449-454, 1997
9. Stefan C, Stalmans W, Bollen M: Threonine autophosphorylation and nucleotidylation of the hepatic membrane protein PC-1. Eur J Biochem 241: 338-342, 1996
10. Umezu-Goto M, Kishi Y, Taira A, Hama K, Dohmae N, Takio K, Yamori T, Mills GB, Inoue K, Aoki J, Arai H: Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J Cell Biol 158: 227-233, 2002
11. Ferry G, Tellier E, Try A, Gres S, Naime I, Simon MF, Rodriguez M, Boucher J, Tack I, Gesta S, Chomarat P, Dieu M, Raes M, Galizzi JP, Valet P, Boutin JA, Saulnier-Blache JS: Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation. Up-regulated expression with adipocyte differentiation and obesity. J Biol Chem 278: 18162-18169, 2003
12. Clair T, Aoki J, Koh E, Bandle RW, Nam SW, Ptaszynska MM, Mills GB, Schiffmann E, Liotta LA, Stracke ML: Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate. Cancer Res 63: 5446-5453, 2003
13. Yang Y, Mou L, Liu N, Tsao MS: Autotaxin expression in non-small-cell lung cancer. Am J Respir Cell Mol Biol 21: 216-222, 1999
14. Kehlen A, Englert N, Seifert A, Klonisch T, Dralle H, Langner J, Hoang-Vu C: Expression, regulation and function of autotaxin in thyroid carcinomas. Int J Cancer 109: 833-838, 2004
15. Yang SY, Lee J, Park CG, Kim S, Hong S, Chung HC, Min SK, Han JW, Lee HW, Lee HY: Expression of autotaxin (NPP-2) is closely linked to invasiveness of breast cancer cells. Clin Exp Metastasis 19: 603-608, 2000
16. Goetzl EJ, Dolezalova H, Kong Y, Zeng L: Dual mechanisms for lysophospholipid induction of proliferation of human breast carcinoma cells. Cancer Res 59: 4732-4737, 1999
17. Kitayama J, Shida D, Sako A, Ishikawa M, Hama K, Aoki J, Arai H, Nagawa H: Over-expression of lysophosphatidic acid receptor-2 in human invasive ductal carcinoma. Breast Cancer Res 6: R640-646, 2004
18. Chen M, O'Connor KL: Integrin alpha6beta4 promotes expression of autotaxin/ENPP2 autocrine motility factor in breast carcinoma cells. Oncogene 24: 5125-5130, 2005
19. Mills GB, Moolenaar WH: The emerging role of lysophosphatidic acid in cancer. Nat Rev Cancer 3: 582-591, 2003
20. Brindley DN: Lipid phosphate phosphatases and related proteins: Signaling functions in development, cell division, and cancer. J Cell Biochem 92: 900-912, 2004
21. Spiegel S, MilstienAS: Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 4: 397-407, 2003
22. Lawler J: The functions of thrombospondin-1 and-2. Curr Opin Cell Biol 12: 634-640, 2000